- Report
- June 2026
- 187 Pages
Global
From €3208EUR$3,545USD£2,740GBP
€3564EUR$3,939USD£3,045GBP
- Report
- January 2026
- 188 Pages
Global
From €3208EUR$3,545USD£2,740GBP
€3564EUR$3,939USD£3,045GBP
- Report
- February 2026
- 250 Pages
Global
From €4063EUR$4,490USD£3,471GBP
- Report
- July 2026
- 177 Pages
Global
From €5294EUR$5,850USD£4,522GBP
- Report
- July 2026
- 372 Pages
Global
From €5294EUR$5,850USD£4,522GBP
- Report
- January 2026
- 185 Pages
Global
From €4072EUR$4,500USD£3,478GBP
- Clinical Trials
- May 2026
- 280 Pages
Global
From €2715EUR$3,000USD£2,319GBP
- Report
- February 2026
- 200 Pages
Global
From €7230EUR$7,990USD£6,176GBP
- Report
- May 2026
- 100 Pages
Global
From €2442EUR$2,699USD£2,086GBP
- Report
- April 2026
- 137 Pages
Global
From €3619EUR$3,999USD£3,091GBP
- Report
- October 2025
- 160 Pages
Global
From €2859EUR$3,160USD£2,443GBP
€3574EUR$3,950USD£3,053GBP
- Report
- July 2025
- 82 Pages
United States
From €3167EUR$3,500USD£2,705GBP
- Report
- August 2025
- 183 Pages
Global
From €3208EUR$3,545USD£2,740GBP
€3564EUR$3,939USD£3,045GBP
- Report
- August 2025
- 184 Pages
Global
From €3208EUR$3,545USD£2,740GBP
€3564EUR$3,939USD£3,045GBP
- Report
- February 2026
- 250 Pages
Global
From €4063EUR$4,490USD£3,471GBP
- Report
- February 2026
- 250 Pages
Global
From €4063EUR$4,490USD£3,471GBP
- Report
- February 2026
- 250 Pages
Global
From €4063EUR$4,490USD£3,471GBP
- Report
- November 2025
- 185 Pages
Global
From €4072EUR$4,500USD£3,478GBP
- Report
- January 2026
- 240 Pages
Global
From €3167EUR$3,500USD£2,705GBP
- Report
- May 2026
- 200 Pages
Global
From €2524EUR$2,789USD£2,156GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more